RxDoctor Payments Data

John Cichon, MD

Otolaryngology · Colorado Springs, CONPI 1144266834

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 99 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by AstraZeneca at 37.8% of the total.

$2,596in general payments, 2019–2025

Across 99 payments — averaging $26.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$982
  • GSK$454
  • Aerin Medical Inc.$208
  • Sanofi$193
  • Regeneron Healthcare Solutions, Inc.$154
  • Takeda Pharmaceuticals U.S.A., Inc.$108
  • plus $496 from 13 others

What the payments were for

  • Food & beverage$2,596100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,596 in reported general payments places this provider in the 75th percentile of 174 otolaryngology providers in Colorado.

See all otolaryngology providers in Colorado

Medicare billing

Part B allowed, 2024
$229,280
Medicare patients
487
Services billed
2,249

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ipratropium Bromide171$4,187
Pilocarpine Hcl20$1,875
Esomeprazole Magnesium48$1,830
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth15$1,796
Fluocinolone Acetonide Oil18$1,290
Fluticasone Propionate76$1,158
Azelastine Hcl32$1,071
Ofloxacin22$351
Gabapentin15$337
Acetazolamide23$262
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav21$194
Prednisone33$184
Mupirocin16$141
Triamcinolone Acetonide11$141
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen29$133

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Colorado Springs

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →